Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$983M |
| 2 |
Meta Platforms (Facebook)
META
|
+$932M |
| 3 |
AbbVie
ABBV
|
+$883M |
| 4 |
Analog Devices
ADI
|
+$461M |
| 5 |
CRH
CRH
|
+$435M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$868M |
| 2 |
Texas Instruments
TXN
|
+$587M |
| 3 |
Advanced Micro Devices
AMD
|
+$531M |
| 4 |
Aon
AON
|
+$529M |
| 5 |
Johnson & Johnson
JNJ
|
+$527M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.5% |
| 2 | Financials | 18.41% |
| 3 | Healthcare | 14.02% |
| 4 | Industrials | 12.82% |
| 5 | Communication Services | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
iShares ESG Aware MSCI EM ETF
ESGE
$6.67B
| $274K | ﹤0.01% |
9,065
+1,698
| +23% | +$53.8K |
|
827
Canadian Imperial Bank of Commerce
CM
$108B
| $266K | ﹤0.01% |
6,900
+2,131
| +45% | +$88K |
|
828
Ionis Pharmaceuticals
IONS
$9.06B
| $262K | ﹤0.01% |
5,769
-20,760
| -78% | -$856K |
|
829
Kroger
KR
$35.1B
| $247K | ﹤0.01% |
5,530
-125
| -2% | -$5.88K |
|
830
AT&T
T
$162B
| $230K | ﹤0.01% |
15,335
-369
| -2% | -$5.41K |
|
831
Atlanticus Holdings
ATLC
$1.69B
| $224K | ﹤0.01% |
7,403
-284
| -4% | -$10.2K |
|
832
Eagle Bancorp
EGBN
$849M
| $204K | ﹤0.01% |
+9,488
| New | +$231K |
|
833
Oil States International
OIS
$501M
| $196K | ﹤0.01% |
+23,373
| New | +$189K |
|
834
Bioventus
BVS
$1.18B
| $188K | ﹤0.01% |
56,982
-2,184
| -4% | -$7.66K |
|
835
Alector
ALEC
$203M
| $142K | ﹤0.01% |
21,951
-841
| -4% | -$5.45K |
|
|
SGMO
836
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $119K | ﹤0.01% |
198,288
-7,597
| -4% | -$8.13K |
|
837
Assured Guaranty
AGO
$3.66B
| – | – |
-17,323
| Closed | -$967K |
|
838
Autohome
ATHM
$2.62B
| – | – |
-44,177
| Closed | -$1.29M |
|
|
AVNS
839
DELISTED
Avanos Medical
AVNS
| – | – |
-68,329
| Closed | -$1.75M |
|
840
American Water Works
AWK
$26.8B
| – | – |
-3,696
| Closed | -$528K |
|
841
Acuity Brands
AYI
$10.7B
| – | – |
-4,167
| Closed | -$680K |
|
842
Bristol-Myers Squibb
BMY
$131B
| – | – |
-3,515
| Closed | -$225K |
|
843
BioXcel Therapeutics
BTAI
$25.6M
| – | – |
-38,970
| Closed | -$4.15M |
|
|
CCRN
844
DELISTED
Cross Country Healthcare
CCRN
| – | – |
-41,538
| Closed | -$1.17M |
|
845
Celanese
CE
$4.82B
| – | – |
-868,444
| Closed | -$101M |
|
|
DQ
846
Daqo New Energy
DQ
$917M
| – | – |
-38,140
| Closed | -$1.51M |
|
847
Emergent Biosolutions
EBS
$272M
| – | – |
-26,878
| Closed | -$198K |
|
848
Ero Copper
ERO
$3.24B
| – | – |
-418,180
| Closed | -$8.46M |
|
849
Fate Therapeutics
FATE
$290M
| – | – |
-34,362
| Closed | -$164K |
|
850
FirstEnergy
FE
$27.4B
| – | – |
-159,781
| Closed | -$6.21M |
|
Similar funds
Massachusetts Financial Services's Q3 2023 Portfolio in Review
As of Q3 2023, Massachusetts Financial Services held 881 positions worth $286B, down 6.2% from $305B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Massachusetts Financial Services's Q3 2023 filing shows 59 new, 333 increased, 435 reduced and 45 closed positions. Its largest new stake was CRH: 7,649,420 shares worth $419M. The largest sale was Merck, an estimated $868M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
- Massachusetts Financial Services's largest Q3 2023 buy was CRH: 7,649,420 shares worth $419M.
- Massachusetts Financial Services added most to Kenvue in Q3 2023, an estimated $983M increase.
- Massachusetts Financial Services's biggest Q3 2023 reduction was Merck, cutting an estimated $868M.
- Massachusetts Financial Services fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $512M.
- Massachusetts Financial Services's ten largest holdings make up 19% of its $286B portfolio in Q3 2023.
- Massachusetts Financial Services opened 59 new positions and closed 45 in Q3 2023.
- Massachusetts Financial Services's portfolio value fell 6.2% quarter-over-quarter to $286B.
Based on Massachusetts Financial Services's 13F filing for Q3 2023, filed 8 Nov 2023.